Company Directory - Novo Nordisk
Company Details - Novo Nordisk
Novo Nordisk
WebsiteBagsværd, Denmark
ISIN: DK0060534915
Novo Nordisk is a global healthcare company based in Denmark, specializing in diabetes care, obesity treatment, and hormone replacement therapy. The company is well-known for its innovative medicines like Ozempic and Wegovy, which are used for the management of diabetes and weight loss.
CCI Score
CCI Score: Novo Nordisk
32.50
-0.14%
Latest Event
Novo Nordisk CEO engages in crisis talks amid authoritarian threats
Novo Nordisk CEO Lars Fruergaard Jørgensen participated in emergency crisis talks with the Danish Prime Minister in response to threats from Trump regarding Greenland, demonstrating the company’s commitment to supporting democratic governance and resisting authoritarian impulses.
Take Action
So what can you do? Support Novo Nordisk by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
DISSENTER
Novo Nordisk is currently rated as a Dissenter.
Latest Events
- JAN172025
Novo Nordisk CEO Lars Fruergaard Jørgensen participated in emergency crisis talks with the Danish Prime Minister in response to threats from Trump regarding Greenland, demonstrating the company’s commitment to supporting democratic governance and resisting authoritarian impulses.
+70
Executive Political Engagement
May 16
The CEO's active engagement in crisis talks with the Danish PM amid threats posed by Trump's administration signifies a strong executive commitment to upholding democratic values and resisting authoritarian pressure. This proactive involvement indicates the company’s stance against far-right authoritarianism, which is a positive signal from an anti-fascist perspective.
Novo Nordisk CEO attends crisis talks with Danish PM amid Trump's Greenland threats
- MAY172024
Novo Nordisk published its 7th Modern Slavery Statement detailing extensive measures, including robust labour rights practices, responsible sourcing audits, and comprehensive human rights training in compliance with multiple international frameworks. The statement outlines strategies to prevent modern slavery, forced labour, and human trafficking throughout its operations and supply chain.
+80
Labor Relations and Human Rights Practices
May 16
The statement details progressive labour practices such as a minimum living wage, enhanced paid leave, prohibition of child labour, and mandatory Ethics & Compliance training, which underscore a strong commitment to human rights in the workplace.
+70
Supply Chain Ethics
May 16
The document outlines a comprehensive Responsible Sourcing Programme, including regular audits, risk assessments, and corrective action plans targeting supply chain vulnerabilities such as forced labour and modern slavery risks, demonstrating dismantling of exploitative practices.
- DEC312023
Novo Nordisk published its 2023 Human Rights Report outlining extensive measures on human rights due diligence, robust employee training, responsible sourcing practices, and grievance mechanisms that align with the UN Guiding Principles on Business and Human Rights.
+80
Labor Relations and Human Rights Practices
May 16
The report details strong internal human rights commitments, mandatory training, clear grievance processes, and protections for employee rights, showcasing a robust approach to labor relations and human rights practices.
+75
Supply Chain Ethics
May 16
The report outlines a comprehensive Responsible Sourcing programme and third-party due diligence process, ensuring that human rights risks in the supply chain are identified and mitigated effectively, thus promoting ethical supplier practices.
- OCT012023
A study by the Danish Institute for Human Rights evaluating Danish companies' adherence to the UN Guiding Principles on Business and Human Rights rated Novo Nordisk 16 out of 24, indicating that while the company has formally committed to respecting human rights, it falls short in transparently communicating its follow-up, compensation, and redress measures.
+10
Business Practices and Ethical Responsibility
May 16
Although Novo Nordisk is the highest scoring Danish company in this study, a 16/24 rating reveals that its disclosures on managing human rights risks—especially regarding follow-up and redress mechanisms—are insufficient. From an anti-fascist perspective emphasizing corporate transparency and accountability in protecting marginalized communities, this partial performance is only a modest positive step.
Danish companies are behind in communicating their human rights efforts
- SEP012023
Novo Nordisk, as a founding member of the Global Business Initiative on Human Rights, has welcomed and committed to reviewing new human rights guidelines. The company is set to provide comments during the open hearing period, underscoring its dedication to integrating comprehensive human rights management into its corporate practices.
+70
Executive Political Engagement
May 16
Novo Nordisk’s active involvement in consultations and open hearings as part of the Global Business Initiative on Human Rights reflects a proactive stance in engaging with and shaping public policy regarding human rights, which is seen as an anti-authoritarian move by promoting transparent and inclusive governance.
+80
Labor Relations and Human Rights Practices
May 16
By welcoming and preparing to evaluate the new human rights guidelines, Novo Nordisk demonstrates a commitment to ethical business practices and the protection of labor and human rights, aligning its strategies with progressive and socially responsible standards.
- AUG072023
Novo Nordisk has actively engaged influential Black leaders and dedicated significant resources to lobbying efforts aimed at overturning Medicare's ban on weight loss drugs. The company sponsored panel discussions at key minority-focused events and participated in streaming shows to advocate for expanded healthcare access, as detailed in the NPR report.
+60
Political Contributions and Lobbying Efforts
May 16
Novo Nordisk’s targeted political contributions and lobbying efforts, particularly through sponsoring panel discussions with influential Black leaders and partnering with organizations like the Congressional Black Caucus Foundation, are designed to support the reversal of Medicare's existing ban on coverage for obesity drugs. While the efforts serve corporate interests, they also potentially expand healthcare access for marginalized communities, which is viewed positively from an anti-fascist perspective.
Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor
- JUL152023
Novo Nordisk retained a new outside lobbying firm, Todd Strategy Group, during the summer as part of a sustained effort that saw it hiring a fifth new lobbying firm in less than a year. The move comes amid a broader campaign to influence legislature on issues including Medicare coverage for obesity treatments and drug pricing provisions.
-60
Political Contributions and Lobbying Efforts
May 16
Novo Nordisk's decision to continuously add new lobbying firms, as evidenced by hiring Todd Strategy Group this summer, underscores its aggressive use of corporate political influence. This extensive lobbying effort raises concerns about the potential for undue influence over public policy and democratic processes, aligning with practices that can undermine transparent governance.
- MAR312023
Novo Nordisk spent $5,239,615 on lobbying activities in 2023, as reported by OpenSecrets. This data highlights the company's active engagement in political lobbying, potentially using its influence to shape policy decisions.
-40
Political Contributions and Lobbying Efforts
May 16
Novo Nordisk's expenditure of over $5 million on lobbying in 2023 demonstrates a significant effort to influence policy. From an anti-fascist perspective, the reliance on corporate political influence raises concerns about potential undue sway over democratic processes, aligning with trends that can empower authoritarian or oligarchic control.
- JAN012023
Novo Nordisk has published its 2023 Responsible Sourcing Standards, outlining rigorous expectations for suppliers regarding anti-corruption, human rights, labor practices, environmental management, and health & safety. The document draws on international frameworks such as the UN Guiding Principles on Business and Human Rights and OECD Guidelines, and requires suppliers to undertake corrective actions if found in breach.
+70
Labor Relations and Human Rights Practices
May 16
The Responsible Sourcing Standards strongly emphasize upholding human rights and ensuring fair labor practices across the supply chain. By mandating compliance with international labor standards, prohibiting forced and child labor, and ensuring fair treatment of workers, Novo Nordisk promotes workers' rights and a more ethical business model.
+60
Supply Chain Ethics
May 16
The document sets high ethical standards for supplier selection and ongoing performance, explicitly requiring responsible sourcing practices and compliance with international standards. This demonstrates a commitment to supply chain ethics by ensuring suppliers are held accountable for their practices, thereby reducing risks of abusive labor and environmental practices that can enable authoritarian corporate behaviors.
Alternatives
Corporation
11.74
Abbott Park, United States
-41.33
Somerset, United States
1.17
Mainz, Germany
-6.49
Amsterdam, Netherlands
-8.59
San Carlos, United States
-24.65
Cambridge, USA
-42.53
Corporation
45.08
Corporation
0.00
Corporation
0.00
Corporate Financials
- Revenue
- 2022
- $19.65B
- Total Assets
- 2022
- $60.20B
- Operating Income
- 2022
- $9.30B
- Total Equity
- 2022
- $38.00B
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 423450
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- 621511
- Medical Laboratories